Quarterly Result7 Oct 2026, 06:00 pm
Indrayani Biotech declares unaudited Q1 FY27 results
AI Summary
Indrayani Biotech Ltd announced its unaudited standalone and consolidated financial results for the quarter ended June 30, 2026. The Board of Directors approved these results, which were recommended by the Audit Committee. The statutory auditors have reviewed the financial results and provided an unmodified opinion. The company also approved the reconstitution of the Audit Committee, Stakeholder Relationship Committee, and Rights Issue Committee.
Key Highlights
- Unaudited standalone and consolidated financial results for Q1 FY27 declared.
- Results approved by the Board of Directors.
- Statutory auditors provided an unmodified review opinion.
- Reconstitution of key Board committees approved.
- Financial results to be published in newspapers and on company website.
Price Impact
More from INDRANIB